CN104330346B - 用于声学流式细胞计量术的方法 - Google Patents
用于声学流式细胞计量术的方法 Download PDFInfo
- Publication number
- CN104330346B CN104330346B CN201410492244.6A CN201410492244A CN104330346B CN 104330346 B CN104330346 B CN 104330346B CN 201410492244 A CN201410492244 A CN 201410492244A CN 104330346 B CN104330346 B CN 104330346B
- Authority
- CN
- China
- Prior art keywords
- granule
- sample
- fluid
- flow
- acoustics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000000684 flow cytometry Methods 0.000 title abstract description 10
- 239000012530 fluid Substances 0.000 claims abstract description 219
- 239000002245 particle Substances 0.000 claims abstract description 37
- 230000005855 radiation Effects 0.000 claims abstract description 17
- 239000012141 concentrate Substances 0.000 claims abstract description 5
- 239000008187 granular material Substances 0.000 claims description 264
- 238000001514 detection method Methods 0.000 claims description 28
- 230000003287 optical effect Effects 0.000 claims description 27
- 230000003993 interaction Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 231
- 210000004027 cell Anatomy 0.000 description 175
- 238000004458 analytical method Methods 0.000 description 32
- 239000002609 medium Substances 0.000 description 30
- 210000004369 blood Anatomy 0.000 description 27
- 239000008280 blood Substances 0.000 description 26
- 238000010586 diagram Methods 0.000 description 22
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 19
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 19
- 239000002699 waste material Substances 0.000 description 17
- 239000007788 liquid Substances 0.000 description 14
- 210000000265 leukocyte Anatomy 0.000 description 13
- 239000000463 material Substances 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 230000035945 sensitivity Effects 0.000 description 11
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 10
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 238000007906 compression Methods 0.000 description 10
- 230000006835 compression Effects 0.000 description 10
- 239000000975 dye Substances 0.000 description 10
- 238000004043 dyeing Methods 0.000 description 10
- 238000000926 separation method Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 210000003677 hemocyte Anatomy 0.000 description 8
- 238000011144 upstream manufacturing Methods 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 229940000351 hemocyte Drugs 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000004005 microsphere Substances 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108010004729 Phycoerythrin Proteins 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 238000004163 cytometry Methods 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- MURGITYSBWUQTI-UHFFFAOYSA-N fluorescin Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C21 MURGITYSBWUQTI-UHFFFAOYSA-N 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 229960004359 iodixanol Drugs 0.000 description 6
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 6
- 229910052747 lanthanoid Inorganic materials 0.000 description 6
- 150000002602 lanthanoids Chemical class 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 230000022131 cell cycle Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 4
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 4
- 229910052771 Terbium Inorganic materials 0.000 description 4
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000013522 chelant Substances 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000011010 flushing procedure Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 4
- 210000005239 tubule Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229910052693 Europium Inorganic materials 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000004054 semiconductor nanocrystal Substances 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 2
- 101100046775 Arabidopsis thaliana TPPA gene Proteins 0.000 description 2
- FOXXZZGDIAQPQI-XKNYDFJKSA-N Asp-Pro-Ser-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O FOXXZZGDIAQPQI-XKNYDFJKSA-N 0.000 description 2
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 238000001069 Raman spectroscopy Methods 0.000 description 2
- 230000018199 S phase Effects 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001461 cytolytic effect Effects 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000000695 excitation spectrum Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 2
- 229960004647 iopamidol Drugs 0.000 description 2
- TYYBFXNZMFNZJT-UHFFFAOYSA-N ioxaglic acid Chemical compound CNC(=O)C1=C(I)C(N(C)C(C)=O)=C(I)C(C(=O)NCC(=O)NC=2C(=C(C(=O)NCCO)C(I)=C(C(O)=O)C=2I)I)=C1I TYYBFXNZMFNZJT-UHFFFAOYSA-N 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- -1 polymethylene Polymers 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 description 1
- 102100022749 Aminopeptidase N Human genes 0.000 description 1
- 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 description 1
- 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 1
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
- 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 description 1
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 description 1
- 102100022297 Integrin alpha-X Human genes 0.000 description 1
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 241000083996 Libanothamnus lucidus Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 108010047357 Luminescent Proteins Proteins 0.000 description 1
- 102000006830 Luminescent Proteins Human genes 0.000 description 1
- BAQCROVBDNBEEB-UBYUBLNFSA-N Metrizamide Chemical compound CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C(=O)N[C@@H]2[C@H]([C@H](O)[C@@H](CO)OC2O)O)=C1I BAQCROVBDNBEEB-UBYUBLNFSA-N 0.000 description 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
- 102000003729 Neprilysin Human genes 0.000 description 1
- 108090000028 Neprilysin Proteins 0.000 description 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000007660 Residual Neoplasm Diseases 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102100027208 T-cell antigen CD7 Human genes 0.000 description 1
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000059 antiamebic agent Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 108091005948 blue fluorescent proteins Proteins 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000001739 density measurement Methods 0.000 description 1
- 229960005423 diatrizoate Drugs 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- JROGBPMEKVAPEH-GXGBFOEMSA-N emetine dihydrochloride Chemical compound Cl.Cl.N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC JROGBPMEKVAPEH-GXGBFOEMSA-N 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 229940029407 ioxaglate Drugs 0.000 description 1
- 229960001707 ioxaglic acid Drugs 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960000554 metrizamide Drugs 0.000 description 1
- GGGDNPWHMNJRFN-UHFFFAOYSA-N metrizoic acid Chemical compound CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I GGGDNPWHMNJRFN-UHFFFAOYSA-N 0.000 description 1
- 229960004712 metrizoic acid Drugs 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 210000000581 natural killer T-cell Anatomy 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- VYNDHICBIRRPFP-UHFFFAOYSA-N pacific blue Chemical compound FC1=C(O)C(F)=C2OC(=O)C(C(=O)O)=CC2=C1 VYNDHICBIRRPFP-UHFFFAOYSA-N 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920003214 poly(methacrylonitrile) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 239000002423 protozoacide Substances 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/41—Refractivity; Phase-affecting properties, e.g. optical path length
- G01N21/45—Refractivity; Phase-affecting properties, e.g. optical path length using interferometric methods; using Schlieren methods
- G01N21/453—Holographic interferometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1404—Handling flow, e.g. hydrodynamic focusing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1404—Handling flow, e.g. hydrodynamic focusing
- G01N2015/142—Acoustic or ultrasonic focussing
Landscapes
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26690709P | 2009-12-04 | 2009-12-04 | |
| US61/266,907 | 2009-12-04 | ||
| US30393810P | 2010-02-12 | 2010-02-12 | |
| US61/303,938 | 2010-02-12 | ||
| US35931010P | 2010-06-28 | 2010-06-28 | |
| US61/359,310 | 2010-06-28 | ||
| CN201080061774.5A CN102762990B (zh) | 2009-12-04 | 2010-11-29 | 用于声学流式细胞计量术的装置、系统、方法和计算机可读介质 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080061774.5A Division CN102762990B (zh) | 2009-12-04 | 2010-11-29 | 用于声学流式细胞计量术的装置、系统、方法和计算机可读介质 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104330346A CN104330346A (zh) | 2015-02-04 |
| CN104330346B true CN104330346B (zh) | 2017-04-12 |
Family
ID=44081725
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080061774.5A Active CN102762990B (zh) | 2009-12-04 | 2010-11-29 | 用于声学流式细胞计量术的装置、系统、方法和计算机可读介质 |
| CN201410492244.6A Active CN104330346B (zh) | 2009-12-04 | 2010-11-29 | 用于声学流式细胞计量术的方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080061774.5A Active CN102762990B (zh) | 2009-12-04 | 2010-11-29 | 用于声学流式细胞计量术的装置、系统、方法和计算机可读介质 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20110134426A1 (enExample) |
| EP (1) | EP2507639B1 (enExample) |
| JP (2) | JP5887275B2 (enExample) |
| CN (2) | CN102762990B (enExample) |
| AU (1) | AU2010326180B2 (enExample) |
| WO (1) | WO2011068764A2 (enExample) |
Families Citing this family (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7340957B2 (en) * | 2004-07-29 | 2008-03-11 | Los Alamos National Security, Llc | Ultrasonic analyte concentration and application in flow cytometry |
| US7835000B2 (en) * | 2006-11-03 | 2010-11-16 | Los Alamos National Security, Llc | System and method for measuring particles in a sample stream of a flow cytometer or the like |
| EP2156178B1 (en) * | 2007-04-02 | 2011-12-21 | Acoustic Cytometry Systems, Inc. | Methods for enhanced analysis of acoustic field focused cells and particles |
| US7837040B2 (en) | 2007-04-09 | 2010-11-23 | Los Alamos National Security, Llc | Acoustic concentration of particles in fluid flow |
| US8083068B2 (en) | 2007-04-09 | 2011-12-27 | Los Alamos National Security, Llc | Apparatus for separating particles utilizing engineered acoustic contrast capture particles |
| US8263407B2 (en) | 2007-10-24 | 2012-09-11 | Los Alamos National Security, Llc | Method for non-contact particle manipulation and control of particle spacing along an axis |
| US8528406B2 (en) * | 2007-10-24 | 2013-09-10 | Los Alamos National Security, LLP | Method for non-contact particle manipulation and control of particle spacing along an axis |
| US9451884B2 (en) | 2007-12-13 | 2016-09-27 | Board Of Trustees Of The University Of Arkansas | Device and method for in vivo detection of clots within circulatory vessels |
| US9144383B2 (en) | 2007-12-13 | 2015-09-29 | The Board Of Trustees Of The University Of Arkansas | Device and method for in vivo noninvasive magnetic manipulation of circulating objects in bioflows |
| US20090156932A1 (en) | 2007-12-13 | 2009-06-18 | Board Of Trustees Of The University Of Arkansas | Device and method for in vivo flow cytometry using the detection of photoacoustic waves |
| US8266950B2 (en) | 2007-12-19 | 2012-09-18 | Los Alamos National Security, LLP | Particle analysis in an acoustic cytometer |
| US8714014B2 (en) | 2008-01-16 | 2014-05-06 | Life Technologies Corporation | System and method for acoustic focusing hardware and implementations |
| US8658734B2 (en) * | 2009-05-11 | 2014-02-25 | Stc.Unm | Synthesis of stable elastomeric negative acoustic contrast particles |
| AU2010326180B2 (en) * | 2009-12-04 | 2015-06-18 | Life Technologies Corporation | Apparatuses, systems, methods, and computer readable media for acoustic flow cytometry |
| JP5437148B2 (ja) * | 2010-04-23 | 2014-03-12 | ベイバイオサイエンス株式会社 | フローサイトメータおよびセルソータ |
| RU2587328C2 (ru) | 2010-05-05 | 2016-06-20 | БЕКМАН КАУЛТЕР БАЙОМЕДИКАЛ, ЭлЭлСи | Диагностическая система и компоненты |
| WO2012098287A1 (en) * | 2011-01-19 | 2012-07-26 | Teknologian Tutkimuskeskus Vtt | Method and system for determining particle size information |
| USD698038S1 (en) | 2011-03-03 | 2014-01-21 | Life Technologies Corporation | Plate loader |
| JP5973471B2 (ja) | 2011-03-03 | 2016-08-23 | ライフ テクノロジーズ コーポレーション | サンプリングプローブ、システム、装置、および方法 |
| WO2013003498A2 (en) * | 2011-06-27 | 2013-01-03 | Life Technologies Corporation | Acoustic cytometry methods and protocols |
| EP2594334A1 (en) | 2011-11-21 | 2013-05-22 | Drive O2 | Sample vial for digital holographic analysis of a liquid cell sample |
| WO2013011001A1 (en) | 2011-07-19 | 2013-01-24 | Ovizio Imaging Systems N.V. | A method and system for detecting and/or classifying cancerous cells in a cell sample |
| EP2761291B1 (en) * | 2011-09-28 | 2016-06-29 | Acousort AB | System and method to separate cells and/or particles |
| EP2626686A1 (en) | 2012-02-13 | 2013-08-14 | Ovizio Imaging Systems NV/SA | Flow cytometer with digital holographic microscope |
| US9458450B2 (en) | 2012-03-15 | 2016-10-04 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
| US9950282B2 (en) | 2012-03-15 | 2018-04-24 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
| JP6110484B2 (ja) * | 2012-06-21 | 2017-04-05 | エスティーシー． ユーエヌエムＳｔｃ．Ｕｎｍ | ラインフォーカシング式光源で励起した多数のサンプル流れからの空間相関集光 |
| EP2898310B1 (en) | 2012-09-20 | 2019-05-01 | Ovizio Imaging Systems NV/SA | Digital holographic microscope with fluid systems |
| CA2884954A1 (en) | 2012-09-25 | 2014-04-03 | Mark S. Smeltzer | Device and method for in vivo photoacoustic diagnosis and photothermal purging of infected blood |
| WO2014062719A2 (en) * | 2012-10-15 | 2014-04-24 | Nanocellect Biomedical, Inc. | Systems, apparatus, and methods for sorting particles |
| US10662408B2 (en) | 2013-03-14 | 2020-05-26 | Inguran, Llc | Methods for high throughput sperm sorting |
| US10371622B2 (en) | 2013-03-14 | 2019-08-06 | Inguran, Llc | Device for high throughput sperm sorting |
| US9757726B2 (en) | 2013-03-14 | 2017-09-12 | Inguran, Llc | System for high throughput sperm sorting |
| CA3026548C (en) | 2013-04-15 | 2022-01-04 | Becton, Dickinson And Company | Medical device for collection of a biological sample |
| CA2909367C (en) * | 2013-04-15 | 2019-01-08 | Becton, Dickinson And Company | Biological fluid separation device and biological fluid separation and testing system |
| US9645080B2 (en) * | 2013-04-16 | 2017-05-09 | University Of Washington | Systems, devices, and methods for separating, concentrating, and/or differentiating between cells from a cell sample |
| DK3004838T3 (da) | 2013-05-28 | 2022-06-20 | Chemometec As | Billeddannende cytometer |
| US10126220B2 (en) * | 2013-07-22 | 2018-11-13 | National Oilwell Varco, L.P. | Systems and methods for determining specific gravity and minerological properties of a particle |
| US9535000B2 (en) * | 2013-09-05 | 2017-01-03 | Bio-Rad Laboratories, Inc. | On-demand particle dispensing system |
| US9963693B2 (en) | 2013-10-21 | 2018-05-08 | Biomet Biologics, Llc | Cell washing device using a wave |
| US9725710B2 (en) | 2014-01-08 | 2017-08-08 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| US9377400B2 (en) | 2014-03-31 | 2016-06-28 | Redshift Systems Corporation | Motion modulation fluidic analyzer system |
| KR20170039250A (ko) | 2014-08-28 | 2017-04-10 | 시스멕스 가부시키가이샤 | 입자 촬상 장치 및 입자 촬상 방법 |
| SG11201702571RA (en) * | 2014-10-01 | 2017-04-27 | Water Optics Technology Pte Ltd | A sensor for particle detection in a fluid |
| CN111948015B (zh) | 2014-10-24 | 2023-10-10 | 生命科技股份有限公司 | 以声学方式沉淀的液-液样品纯化系统 |
| JP6646298B2 (ja) * | 2014-12-16 | 2020-02-14 | 国立大学法人 東京大学 | ロープ状構造体の製造方法 |
| WO2016100954A1 (en) * | 2014-12-19 | 2016-06-23 | Captl Llc | Flow cytometry using hydrodynamically planar flow |
| EP4278979A3 (en) | 2014-12-31 | 2024-02-21 | BioVentures, LLC | Devices and methods for fractionated photoacoustic flow cytometry |
| US11959907B2 (en) * | 2015-01-12 | 2024-04-16 | Instrumentation Laboratory Company | Spatial separation of particles in a particle containing solution for biomedical sensing and detection |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
| WO2016181968A1 (ja) * | 2015-05-13 | 2016-11-17 | 株式会社エアレックス | パーティクル制御方法 |
| JP6713730B2 (ja) | 2015-05-20 | 2020-06-24 | シスメックス株式会社 | 細胞検出装置および細胞検出方法 |
| US10036698B2 (en) | 2015-06-19 | 2018-07-31 | Captl Llc | Time-sequential cytometry |
| US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| WO2017054839A1 (en) * | 2015-09-28 | 2017-04-06 | Siemens Healthcare Gmbh | A technique for aligning a non-spherical biological entity in a flow cell |
| US10823657B2 (en) * | 2015-12-23 | 2020-11-03 | Siemens Healthcare Gmbh | Flow cell for analyzing particles in a liquid to be examined |
| US10648900B2 (en) * | 2015-12-23 | 2020-05-12 | Becton, Dickinson And Company | Multi-color flow cytometric analysis of samples with low cell numbers |
| EP3196631A1 (en) | 2016-01-19 | 2017-07-26 | Ovizio Imaging Systems NV/SA | Digital holographic microscope with electro-fluidic system, said electro-fluidic system and methods of use |
| US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| FR3051556A1 (fr) * | 2016-05-18 | 2017-11-24 | Biocytex | Utilisation de marqueurs fluorescents pour la detection de cible biologique dans un echantillon |
| JP7026063B2 (ja) * | 2016-07-01 | 2022-02-25 | ライフ テクノロジーズ コーポレーション | 粒子を濃縮するための方法、システム、および装置 |
| EP3493907B1 (en) * | 2016-08-02 | 2023-10-04 | IMEC vzw | Method and arrangement for focusing objects in a flow |
| EP3300804B1 (en) * | 2016-09-30 | 2020-04-08 | ARKRAY, Inc. | Method for separating particles, separation apparatus, and separation system |
| JP2020513248A (ja) | 2016-10-19 | 2020-05-14 | フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． | 音響による親和性細胞抽出 |
| US10436697B2 (en) | 2016-11-19 | 2019-10-08 | Cytek Biosciences, Inc. | Flow cytometery system with fluidics control system |
| EP4390369A3 (en) | 2016-11-19 | 2025-01-01 | Cytek Biosciences, Inc. | Flow cytometry systems with stepper flow control valve |
| CN106556561A (zh) * | 2016-11-28 | 2017-04-05 | 中国科学院苏州生物医学工程技术研究所 | 一种流体粒子运动控制装置 |
| CN106872339A (zh) * | 2017-01-10 | 2017-06-20 | 中国科学院苏州生物医学工程技术研究所 | 一种粒子排序方法及其装置和用途 |
| WO2018147462A1 (ja) * | 2017-02-10 | 2018-08-16 | 東ソー株式会社 | 粒子検出装置及び粒子検出方法 |
| KR102585276B1 (ko) | 2017-03-31 | 2023-10-05 | 라이프 테크놀로지스 코포레이션 | 이미징 유세포 분석을 위한 장치, 시스템, 및 방법 |
| CN107202773B (zh) * | 2017-06-01 | 2019-07-05 | 重庆大学 | 一种利用聚苯乙烯球的细胞周期散射光强模型建立方法 |
| CN111491555B (zh) | 2017-10-16 | 2024-06-21 | 麻省理工学院 | 用于非侵入性血液测量的系统、装置和方法 |
| DE102017126128A1 (de) | 2017-11-08 | 2019-05-09 | Endress+Hauser SE+Co. KG | System und Verfahren zur ortsaufgelösten Bestimmung von zumindest einer physikalischen oder chemischen Prozessgröße |
| US10785574B2 (en) | 2017-12-14 | 2020-09-22 | Flodesign Sonics, Inc. | Acoustic transducer driver and controller |
| WO2019119368A1 (zh) * | 2017-12-21 | 2019-06-27 | 深圳先进技术研究院 | 一种声驱动的流式细胞检测装置 |
| CN109946217B (zh) * | 2017-12-21 | 2021-08-24 | 深圳先进技术研究院 | 一种声驱动的流式细胞检测装置 |
| CN108120665A (zh) * | 2017-12-28 | 2018-06-05 | 无锡奥芬光电科技有限公司 | 单色结构光检查微小颗粒的方法及设备 |
| CN108444897B (zh) * | 2018-03-06 | 2021-04-13 | 山东大学 | 基于光片照明与鞘流技术的免标记微流控细胞仪及方法 |
| US11698364B2 (en) | 2018-06-27 | 2023-07-11 | University Of Washington | Real-time cell-surface marker detection |
| CN112805548B (zh) | 2018-10-30 | 2025-03-11 | 贝克顿·迪金森公司 | 具有对准窗口的颗粒分选模块、系统及其使用方法 |
| CN109540771B (zh) * | 2018-12-18 | 2020-12-08 | 武汉大学 | 一种精准分选白细胞亚型的声光微流控芯片及其分选方法 |
| US11788965B2 (en) * | 2019-02-21 | 2023-10-17 | Arizona Board Of Regents On Behalf Of Arizona State University | Folic acid functionalized copper sulfide nanoparticles for the detection of ovarian cancer cells in flow |
| US20220178811A1 (en) * | 2019-04-18 | 2022-06-09 | Fundació Institute De Ciències Fotòniques | Opto-Fluidic Apparatus for Individual Interrogation of Organisms |
| JP2022531934A (ja) * | 2019-05-15 | 2022-07-12 | フロデザイン ソニックス， インク． | 音響エッジ効果 |
| US11160492B2 (en) | 2019-07-24 | 2021-11-02 | Massachusetts Institute Of Technology | Finger inserts for a nailfold imaging device |
| JP7729538B2 (ja) * | 2019-12-29 | 2025-08-26 | アプライド セルズ インク | 生物学的実体を分離するための方法および装置 |
| CN115699108A (zh) | 2020-05-28 | 2023-02-03 | 露科实验室股份有限公司 | 一种从无创性毛细血管视频中检测白细胞和/或白细胞亚型的方法 |
| EP4162254A4 (en) * | 2020-06-03 | 2024-06-05 | Kinetic River Corp. | CONFIGURABLE PARTICLE ANALYZER DEVICES AND METHODS |
| JP7042301B2 (ja) * | 2020-06-04 | 2022-03-25 | シスメックス株式会社 | 細胞検出方法 |
| CN117203519A (zh) * | 2020-11-25 | 2023-12-08 | 希里斯公司 | 用于个人化医疗和药物开发的微器官球体(micro-organosphere) |
| EP4086607B1 (en) * | 2021-05-07 | 2024-12-04 | Deutsches Elektronen-Synchrotron DESY | Device and system for bunching of sample particles |
| CN119101655A (zh) * | 2024-10-09 | 2024-12-10 | 上海交通大学 | 一种基于单波束聚焦声场三维空间捕获细胞方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2739572A1 (en) * | 1999-12-03 | 2001-06-07 | Xy, Llc | Improved flow cytometer nozzle and flow cytometer sample handling methods |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284412A (en) * | 1979-07-13 | 1981-08-18 | Ortho Diagnostics, Inc. | Method and apparatus for automated identification and enumeration of specified blood cell subclasses |
| US4298836A (en) * | 1979-11-23 | 1981-11-03 | Coulter Electronics, Inc. | Particle shape determination |
| JPS61153546A (ja) * | 1984-12-26 | 1986-07-12 | Canon Inc | 粒子解析装置 |
| JPS61159135A (ja) * | 1984-12-31 | 1986-07-18 | Canon Inc | 粒子解析装置 |
| JPS62207933A (ja) * | 1986-03-08 | 1987-09-12 | Canon Inc | 粒子解析装置 |
| US4786165A (en) * | 1986-07-10 | 1988-11-22 | Toa Medical Electronics Co., Ltd. | Flow cytometry and apparatus therefor |
| JPH0449573Y2 (enExample) * | 1987-08-28 | 1992-11-20 | ||
| JPH0277636A (ja) * | 1988-09-13 | 1990-03-16 | Canon Inc | 粒子測定装置 |
| JP3052665B2 (ja) * | 1993-01-26 | 2000-06-19 | 株式会社日立製作所 | フローセル装置 |
| JPH07270301A (ja) * | 1994-03-31 | 1995-10-20 | Hitachi Ltd | フロー式粒子画像解析方法およびその装置 |
| JP3375203B2 (ja) * | 1994-08-08 | 2003-02-10 | シスメックス株式会社 | 細胞分析装置 |
| JPH08297121A (ja) * | 1995-04-26 | 1996-11-12 | Hitachi Ltd | 粒子分析装置 |
| JPH09126989A (ja) * | 1995-11-07 | 1997-05-16 | Hitachi Ltd | フロー式粒子画像解析装置 |
| US5895869A (en) * | 1995-11-17 | 1999-04-20 | Mwi, Inc. | Method and apparatus for analyzing particulate matter |
| GB9707096D0 (en) * | 1997-04-08 | 1997-05-28 | Smithkline Beecham Plc | Novel device |
| US6074879A (en) * | 1997-06-23 | 2000-06-13 | Bayer Corporation | Synthetic polymer particles for use as standards and calibrators in flow cytometry |
| US5880474A (en) * | 1997-08-29 | 1999-03-09 | Becton Dickinson And Company | Multi-illumination-source flow particle analyzer with inter-location emissions crosstalk cancelation |
| US5895764A (en) * | 1997-11-24 | 1999-04-20 | University Of New Mexico | Controlled sheath flow injection cytometry |
| US6067157A (en) * | 1998-10-09 | 2000-05-23 | University Of Washington | Dual large angle light scattering detection |
| US6473171B1 (en) * | 1999-01-15 | 2002-10-29 | Coors Brewing Company | Biocompatible apparatus for ultrasensitive and rapid detection of contaminants in liquids |
| US6249341B1 (en) * | 1999-01-25 | 2001-06-19 | Amnis Corporation | Imaging and analyzing parameters of small moving objects such as cells |
| US6890487B1 (en) * | 1999-09-30 | 2005-05-10 | Science & Technology Corporation ©UNM | Flow cytometry for high throughput screening |
| US20020102595A1 (en) * | 2001-01-29 | 2002-08-01 | Davis Lloyd Mervyn | Methods for detection of incorporation of a nucleotide onto a nucleic acid primer |
| US6467350B1 (en) * | 2001-03-15 | 2002-10-22 | The Regents Of The University Of California | Cylindrical acoustic levitator/concentrator |
| JP2004535572A (ja) * | 2001-06-13 | 2004-11-25 | ケニス エフ． ウーヘンハイマー， | 自動化流体操作システムおよび方法 |
| US20030110840A1 (en) * | 2001-07-24 | 2003-06-19 | Arriaga Edgar A. | Systems and methods for detecting a particle |
| US7201875B2 (en) * | 2002-09-27 | 2007-04-10 | Becton Dickinson And Company | Fixed mounted sorting cuvette with user replaceable nozzle |
| US7340957B2 (en) * | 2004-07-29 | 2008-03-11 | Los Alamos National Security, Llc | Ultrasonic analyte concentration and application in flow cytometry |
| EP2156178B1 (en) * | 2007-04-02 | 2011-12-21 | Acoustic Cytometry Systems, Inc. | Methods for enhanced analysis of acoustic field focused cells and particles |
| US7837040B2 (en) * | 2007-04-09 | 2010-11-23 | Los Alamos National Security, Llc | Acoustic concentration of particles in fluid flow |
| US8083068B2 (en) * | 2007-04-09 | 2011-12-27 | Los Alamos National Security, Llc | Apparatus for separating particles utilizing engineered acoustic contrast capture particles |
| US8266950B2 (en) * | 2007-12-19 | 2012-09-18 | Los Alamos National Security, LLP | Particle analysis in an acoustic cytometer |
| US8714014B2 (en) * | 2008-01-16 | 2014-05-06 | Life Technologies Corporation | System and method for acoustic focusing hardware and implementations |
| US20100009333A1 (en) * | 2008-07-08 | 2010-01-14 | Beckman Coulter, Inc. | Methods for Acoustic Particle Focusing in Biological Sample Analyzers |
| AU2010326180B2 (en) * | 2009-12-04 | 2015-06-18 | Life Technologies Corporation | Apparatuses, systems, methods, and computer readable media for acoustic flow cytometry |
-
2010
- 2010-11-29 AU AU2010326180A patent/AU2010326180B2/en not_active Ceased
- 2010-11-29 CN CN201080061774.5A patent/CN102762990B/zh active Active
- 2010-11-29 US US12/955,282 patent/US20110134426A1/en not_active Abandoned
- 2010-11-29 JP JP2012542118A patent/JP5887275B2/ja active Active
- 2010-11-29 EP EP10834985.3A patent/EP2507639B1/en active Active
- 2010-11-29 WO PCT/US2010/058242 patent/WO2011068764A2/en not_active Ceased
- 2010-11-29 CN CN201410492244.6A patent/CN104330346B/zh active Active
-
2016
- 2016-02-15 JP JP2016025611A patent/JP6336496B2/ja active Active
-
2017
- 2017-07-06 US US15/643,019 patent/US20180067044A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2739572A1 (en) * | 1999-12-03 | 2001-06-07 | Xy, Llc | Improved flow cytometer nozzle and flow cytometer sample handling methods |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102762990A (zh) | 2012-10-31 |
| AU2010326180B2 (en) | 2015-06-18 |
| JP2016128832A (ja) | 2016-07-14 |
| EP2507639A2 (en) | 2012-10-10 |
| JP5887275B2 (ja) | 2016-03-16 |
| WO2011068764A2 (en) | 2011-06-09 |
| US20180067044A1 (en) | 2018-03-08 |
| EP2507639B1 (en) | 2020-04-01 |
| JP6336496B2 (ja) | 2018-06-06 |
| CN104330346A (zh) | 2015-02-04 |
| WO2011068764A3 (en) | 2011-10-13 |
| AU2010326180A1 (en) | 2012-07-12 |
| EP2507639A4 (en) | 2017-12-27 |
| US20110134426A1 (en) | 2011-06-09 |
| JP2013513109A (ja) | 2013-04-18 |
| CN102762990B (zh) | 2014-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104330346B (zh) | 用于声学流式细胞计量术的方法 | |
| US12188856B2 (en) | Particle analyzing systems and methods using acoustic radiation pressure | |
| JP2013513109A5 (enExample) | ||
| JP4782844B2 (ja) | 少なくとも２つの細胞集団を区別する方法及び応用 | |
| AU2015224429B2 (en) | Apparatuses, systems, methods, and computer readable media for acoustic flow cytometry | |
| Gheewala et al. | Available online through www. jpronline. info |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |